Due Diligence Guide · Medical Billing Company

Due Diligence Guide for Acquiring a Medical Billing Company

Verify revenue quality, compliance history, and operational integrity before acquiring an RCM business in the $1M–$5M revenue range.

Find Medical Billing Company Acquisition Targets

Acquiring a medical billing company requires scrutiny beyond standard financial review. Buyers must assess HIPAA exposure, client contract durability, coder certifications, and technology stack viability. Deals typically close at 3.5–6x EBITDA with SBA 7(a) financing and earnout provisions tied to client retention.

Medical Billing Company Due Diligence Phases

01

Phase 1: Financial and Revenue Quality Review

Verify that reported revenue reflects durable, recurring client contracts rather than one-time or declining billing relationships across the practice portfolio.

Client Revenue Concentration Analysiscritical

Break down revenue by client and specialty. Flag any single practice exceeding 25–30% of total billings, as concentration above this threshold significantly increases acquisition risk.

Net Collection Rate Verificationcritical

Validate net collection rates by specialty against industry benchmarks. Rates below 95% may signal denial management failures, coding errors, or deteriorating payer relationships.

Recurring vs. One-Time Revenue Classificationimportant

Confirm that monthly billing volumes reflect stable percentage-of-collections or flat-fee contracts, not project-based or transitional billing arrangements inflating trailing revenue.

02

Phase 2: Compliance and Regulatory Risk Assessment

Evaluate HIPAA compliance posture, payer audit history, and billing practice integrity to quantify regulatory liability before committing to purchase price.

HIPAA and BAA Documentation Reviewcritical

Confirm signed Business Associate Agreements exist with all clients and vendors. Review security risk assessments, breach logs, and any Office for Civil Rights correspondence or settlement history.

Payer Audit and Clawback Historycritical

Request documentation of any Medicare, Medicaid, or commercial payer audits in the past five years. Unresolved clawback demands or RAC audit findings represent direct post-close financial liability.

Coding Compliance and Documentation Standardsimportant

Assess whether billing practices align with current CMS guidelines. Informal or undocumented upcoding patterns create fraud and abuse exposure that can survive the acquisition transaction.

03

Phase 3: Operations, Technology, and Key-Person Risk

Assess whether the business can operate independently post-close by evaluating staff certifications, documented workflows, and technology infrastructure sustainability.

Technology Stack and EHR Integration Auditcritical

Inventory all billing software licenses, practice management system integrations, and cybersecurity tools. Identify legacy systems lacking vendor support or current EHR API compatibility.

Coder and Staff Certification Verificationimportant

Confirm CPC or CCS credentials for all active coders and review staff tenure. High turnover or uncredentialed staff signals operational fragility and potential billing accuracy issues.

Owner Dependency and Transition Planningimportant

Determine whether the owner manages all client relationships and system access. Absence of second-tier management increases earnout risk and post-close client attrition probability.

Medical Billing Company-Specific Due Diligence Items

  • Request specialty-level denial rate reports for the trailing 12 months to identify systematic coding or credentialing issues by provider type.
  • Verify that all client contracts include assignment clauses permitting transfer of the billing agreement to an acquiring entity without client consent requirements.
  • Confirm the company maintains current payer enrollment and credentialing for all serviced providers, as lapses directly delay post-acquisition claim submissions.
  • Assess cybersecurity posture including endpoint protection, data encryption, and access controls given PHI handling obligations under HIPAA Security Rule.
  • Evaluate fee structure mix between percentage-of-collections and flat-fee contracts, as percentage models carry more revenue volatility tied to practice patient volume fluctuations.

Frequently Asked Questions

What EBITDA multiple should I expect to pay for a medical billing company?

Lower middle market medical billing companies typically trade at 3.5–6x EBITDA. Higher multiples reflect diversified client bases, strong net collection rates above 95%, and proprietary EHR integrations with documented renewal history.

How do I assess client retention risk before the deal closes?

Review contract assignment clauses, average client tenure, and termination notice periods. Earnout structures tying 15–25% of purchase price to 12-month post-close retention are standard risk mitigation tools in RCM acquisitions.

Can I use an SBA 7(a) loan to acquire a medical billing company?

Yes. Medical billing companies are SBA-eligible service businesses. Buyers typically finance 80–90% through SBA 7(a) loans with a seller note covering the remainder, subject to demonstrated EBITDA and clean compliance history.

What is the biggest compliance risk when acquiring a medical billing company?

Undisclosed payer audit clawback liability and unsigned BAAs represent the most acute risks. Buyers should require a compliance rep and warranty in the purchase agreement and consider representations and warranties insurance for larger transactions.

More Medical Billing Company Guides

Find Medical Billing Company businesses ready for acquisition

DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.

Start finding deals — free

No credit card required